Connect with us

Hi, what are you looking for?

Captain Of Success
Top Stories

Stock Markets

Probe on alleged wasted meds, supplies eyed

STOCK PHOTO | Image by aleksandarlittlewolf on Freepik

A CONGRESSMAN on Thursday urged the House of Representatives to investigate the alleged P18.7 billion worth of wasted medical supplies and medicines by the Health department.

In a statement, Party-list Rep. Eduardo J. Villanueva, Jr. said he filed House Resolution (HR) No. 2127 in December last year to look into the P85 million, P7.43 billion, and P11.18 billion worth of “expired, nearly-expired, damaged, overstocked, or undistributed” medicines and medical supplies under the Health department, according to audit reports in 2021, 2022, and 2023, respectively.

“The increasing trend of unutilized medical supplies in recent years is very alarming and still haunts us. While millions of Filipinos struggle to access affordable medicines and healthcare, billions in public funds are being wasted due to inefficiencies,” he said.

“With limited fiscal space, we cannot afford to waste even a single peso,” he added. — Kenneth Christiane L. Basilio

    You May Also Like

    Stock Markets

    SULA Spirits celebrates Filipino artistry with bottles that are as refined as the craft they hold. Have you ever wondered how the perfect day...

    Finance

    Sara Davies, the Dragons’ Den entrepreneur, is set to regain control of Crafter’s Companion, the craft supply business she founded, through a fast-tracked pre-pack...

    Finance

    Businesses shed jobs at the fastest pace in four years last month after higher employment costs and mounting uncertainty from the autumn budget dented...

    Finance

    Millions of people across the UK are at risk of penalties after HM Revenue & Customs (HMRC) revealed that 5.4 million taxpayers have yet...

    Disclaimer: CaptainOfSuccess.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice.
    The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.